Trial
NCT02594566
Safety, Tolerability, and Immunogenicity of a Cytomegalovirus DNA Vaccine
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Virginia Commonwealth University
Collaborators
Vical
Condition
Congenital Cytomegalovirus Infection
Intervention
CyMVectin
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-03-01